Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-30.81%EBITDA Margin
VS
Market
Sector
Industry
History
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information
Ticker
YMABCompany Name
Y-MABS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQY-MABS THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
YMAB - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -26.3M | -30.81% | $ 85.39M |
| 3/31/2025 | $ -30.39M | -34.28% | $ 88.66M |
| 12/31/2024 | $ -30.67M | -34.97% | $ 87.69M |
| 9/30/2024 | $ -27.87M | -32.96% | $ 84.55M |
| 6/30/2024 | $ -27M | -31.2% | $ 86.55M |
| 3/31/2024 | $ -24.37M | -28.84% | $ 84.5M |
| 12/31/2023 | $ -24.94M | -29.4% | $ 84.82M |
| 9/30/2023 | $ -22.82M | -24.57% | $ 92.9M |
| 6/30/2023 | $ -41.03M | -48.28% | $ 84.99M |
| 3/31/2023 | $ -73.79M | -98.34% | $ 75.03M |
Key Performance Insights, Last 5 Years
- Y-MABS THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at 0%.
- Over the past 5 years, Y-MABS THERAPEUTICS INC's average EBITDA % has been -136.45%.
- The median EBITDA % for Y-MABS THERAPEUTICS INC during this period was -80.68%
- Y-MABS THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -24.57%.
- The lowest EBITDA % recorded by Y-MABS THERAPEUTICS INC in the same timeframe -576.09%
Y-MABS THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for Y-MABS THERAPEUTICS INC is calculated as follows: EBITDA [ $ -123.24M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ] YMAB - EBITDA Margin, Last 5 years
-576.09%
Minimum
Dec 31, 2020
-24.57%
Maximum
Sep 30, 2023
-136.45%
Average
-80.68%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |